Activ Surgical: Clinical Trials

3 unknown, 1 not yet recruiting, 1 withdrawn. 5 Not applicable.

By phase and status

Phase	Trials	Status
Not applicable	5	Unknown 3, Not yet recruiting 1, Withdrawn 1

Follow Activ Surgical: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
A Prospective Study Assessing ActivSight Imaging for Intraoperative Perfusion Evaluation in Left-Sided Colectomy ActivSight™ Intraoperative Imaging System - Colorectal Cancer	Not applicable	Not yet recruiting	Activ Surgical	150	2026-03-01	2026-03-06
Feasibility and Utility of Artificial Intelligence (AI) / Machine Learning (ML) - Driven Advanced Intraoperative Visualization and Identification of Critical Anatomic Structures and Procedural Phases in Laparoscopic Cholecystectomy ICG - Cholecystitis, Cholelithiasis	Not applicable	Unknown	Activ Surgical	120	2023-08-01	2024-02-21
Utility and Usability of ActivSight™ Laser Speckle Imaging in Visualization of Tissue Perfusion and Blood Flow During Esophageal Surgery in Humans ActivSight - Esophagus Cancer, Esophageal Cancer	Not applicable	Unknown	Activ Surgical	70	2023-04-01	2024-02-21
Safety and Feasibility of ActivSight(tm) in the Identification of The Ureter Via Riboflavin Fluorescence Investigational Safety and Feasibility - Surgical Procedure, Unspecified	Not applicable	Withdrawn	Activ Surgical		2023-03-01	2024-08-02
Safety and Feasibility of ActivSightTM in Human ActivSight - Acute Cholecystitis, Colorectal Cancer	Not applicable	Unknown	Activ Surgical	67	2020-11-17	2024-02-21

Conditions studied

Colorectal Neoplasms (2)  ·  Adenocarcinoma Of Esophagus (1)  ·  Biliary Dyskinesia (1)  ·  Cholecystitis (1)  ·  Cholecystitis, Acute (1)  ·  Cholelithiasis (1)  ·  Diverticulitis, Colonic (1)  ·  Esophageal Diseases (1)  ·  Esophageal Neoplasms (1)  ·  Esophageal Squamous Cell Carcinoma (1)  ·  Inflammatory Bowel Diseases (1)  ·  Neoplasms (1)  ·  Obesity, Morbid (1)

Countries

United States (4)

Top investigators

Peter Kim, MD, PhD (1)